CompaniesGenelabs Technologies

Genelabs Technologies

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (4)
View all

Total Trials

4

As Lead Sponsor

4

As Collaborator

0

Total Enrollment

309

By Phase

PHASE3: 3PHASE2: 1

By Status

COMPLETED: 2UNKNOWN: 2
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
NCT00037128
Hover over trial bars to see details

Recent Trials

NCT00082511Lead Sponsor
GL701 (Prestara™) in Women With Systemic Lupus Erythematosus Receiving Treatment With Glucocorticoids
PHASE3Completed
114 participants
Started: Jul 31, 2003 · Completed: Aug 31, 2005
NCT00053560Lead Sponsor
To Assess Prevention of Bone Loss in Women With Lupus Receiving Treatment With Glucocorticoids
PHASE3Unknown
155 participants
Started: Dec 31, 2002 · Completed: Aug 31, 2004
NCT00037128Lead Sponsor
Study of GL701 in Men With Systemic Lupus Erythematosus
PHASE3Unknown
40 participants
Started: Mar 31, 1998
NCT00001989Lead Sponsor
A Randomized Phase II Efficacy, Activity and Safety Study of GLQ223 Alone and in Combination With Zidovudine in Symptomatic HIV-Infected Patients Without Prior Treatment With GLQ223 or Trichosanthin
PHASE2Completed
Related Companies
Gsk
acquired